Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 187
8
Diseases
12
Unique genes
0.375
Avg. similarity score
Annular epidermolytic ichthyosis
Most-connected disease (7 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Annular epidermolytic ichthyosis
Congenital reticular ichthyosiform erythroderma
Epidermolytic ichthyosis
Diffuse nonepidermolytic palmoplantar keratoderma
Epidermolytic hyperkeratosis
Keratosis of greither
Epidermolytic palmoplantar keratoderma
Keratosis
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Annular epidermolytic ichthyosis | 7 | 7 | 2 |
| Congenital reticular ichthyosiform erythroderma | 7 | 7 | 2 |
| Epidermolytic ichthyosis | 7 | 7 | 2 |
| Diffuse nonepidermolytic palmoplantar keratoderma | 6 | 6 | 1 |
| Epidermolytic hyperkeratosis | 6 | 6 | 2 |
| Keratosis of greither | 6 | 6 | 1 |
| Epidermolytic palmoplantar keratoderma | 5 | 5 | 3 |
| Keratosis | 4 | 4 | 10 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| KRT1 | 8 / 8 | Annular epidermolytic ichthyosis, Congenital reticular ichthyosiform erythroderma, Diffuse nonepidermolytic palmoplantar keratoderma, Epidermolytic hyperkeratosis and 4 more |
| KRT10 | 5 / 8 | Annular epidermolytic ichthyosis, Congenital reticular ichthyosiform erythroderma, Epidermolytic hyperkeratosis, Epidermolytic ichthyosis and 1 more |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Chemical carcinogenesis - reactive oxygen species | KEGG | 5 / 227 | 22.0× | 1.64e-6 | 7.45e-5 ✓ sig. |
| Formation of the cornified envelope | Reactome | 4 / 130 | 30.8× | 6.07e-6 | 2.21e-4 ✓ sig. |
| Fluid shear stress and atherosclerosis | KEGG | 4 / 141 | 28.4× | 8.38e-6 | 2.89e-4 ✓ sig. |
| Keratinization | Reactome | 4 / 152 | 26.3× | 1.13e-5 | 3.71e-4 ✓ sig. |
| Hepatocellular carcinoma | KEGG | 4 / 170 | 23.5× | 1.76e-5 | 5.37e-4 ✓ sig. |
| Staphylococcus aureus infection | KEGG | 3 / 99 | 30.3× | 1.13e-4 | 2.48e-3 ✓ sig. |
| Estrogen signaling pathway | KEGG | 3 / 139 | 21.6× | 3.09e-4 | 5.50e-3 ✓ sig. |
| Pathways in cancer | KEGG | 4 / 533 | 7.5× | 1.43e-3 | 1.78e-2 ✓ sig. |
| Events associated with phagocytolytic activity of PMN cells | Reactome | 1 / 2 | 500× | 2.00e-3 | 2.28e-2 ✓ sig. |
| Regulation of TP53 Expression | Reactome | 1 / 2 | 500× | 2.00e-3 | 2.28e-2 ✓ sig. |
| Parkinson disease | KEGG | 3 / 268 | 11.2× | 2.08e-3 | 2.35e-2 ✓ sig. |
| Platinum drug resistance | KEGG | 2 / 75 | 26.7× | 2.44e-3 | 2.64e-2 ✓ sig. |
| Drug metabolism - other enzymes | KEGG | 2 / 81 | 24.7× | 2.84e-3 | 2.95e-2 ✓ sig. |
| Longevity regulating pathway | KEGG | 2 / 90 | 22.2× | 3.49e-3 | 3.42e-2 ✓ sig. |
| Transcriptional activation of cell cycle inhibitor p21 | Reactome | 1 / 4 | 250× | 3.99e-3 | 3.77e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| response to oxidative stress | GO:0006979 | 6 / 146 | 64.0× | 1.82e-10 | 4.93e-8 ✓ sig. |
| intermediate filament organization | GO:0045109 | 4 / 70 | 89.0× | 8.74e-8 | 1.08e-5 ✓ sig. |
| morphogenesis of an epithelium | GO:0002009 | 3 / 51 | 91.6× | 4.14e-6 | 2.58e-4 ✓ sig. |
| response to xenobiotic stimulus | GO:0009410 | 4 / 248 | 25.1× | 1.38e-5 | 6.71e-4 ✓ sig. |
| protein heterotetramerization | GO:0051290 | 2 / 16 | 195× | 4.51e-5 | 1.67e-3 ✓ sig. |
| peptide cross-linking | GO:0018149 | 2 / 19 | 164× | 6.43e-5 | 2.17e-3 ✓ sig. |
| hydrogen peroxide catabolic process | GO:0042744 | 2 / 21 | 148× | 7.88e-5 | 2.53e-3 ✓ sig. |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 2 / 34 | 91.6× | 2.10e-4 | 5.21e-3 ✓ sig. |
| establishment of skin barrier | GO:0061436 | 2 / 37 | 84.2× | 2.49e-4 | 5.90e-3 ✓ sig. |
| reactive oxygen species metabolic process | GO:0072593 | 2 / 45 | 69.2× | 3.69e-4 | 7.73e-3 ✓ sig. |
| cellular response to glucose starvation | GO:0042149 | 2 / 50 | 62.3× | 4.55e-4 | 8.97e-3 ✓ sig. |
| response to UV | GO:0009411 | 2 / 54 | 57.7× | 5.31e-4 | 9.98e-3 ✓ sig. |
| response to amitrole | GO:0072722 | 1 / 1 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |
| negative regulation of helicase activity | GO:0051097 | 1 / 1 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |
| regulation of intrinsic apoptotic signaling pathway by p53 class mediator | GO:1902253 | 1 / 1 | 1,557× | 6.42e-4 | 1.13e-2 ✓ sig. |